Combination of drugs: Statins and fibrates;Associação de medicamentos: Estatinas e fibratos

Arquivos Brasileiros de Cardiologia

Volumn 85, Issue SUPPL. 5, 2005, Pages 34-35

  Xavier, Hermes Toros ^a  

^a Faculdade de Ciencias   (Brazil)

Author keywords

Fibrates; Rhabdomyolysis; Statins

Indexed keywords

BEZAFIBRATE; CERIVASTATIN; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; DIABETES MELLITUS; DRUG SAFETY; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERTRIGLYCERIDEMIA; INJURY; KIDNEY FAILURE; MONOTHERAPY; MYOPATHY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RHABDOMYOLYSIS; RISK ASSESSMENT;

EID: 31144460348     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2005002400009     Document Type: Review

References (4)

1. Shek A, Ferril MJ. Statin-fibrate combination therapy. Ann Pharmacother. 2001; 35:908-917.
2. Evans M, Rees A. The myotoxicity of statins. Curr Opin Lipidol. 2002;13:415-420.
3. Ballantyne CM et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553-564.
4. Bellosta S et al. Safety of statins: focus on clinical pharmacokinets and drug interections. Circulation. 2004;109(suppl lIII):):III-50-III-57).